Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT01733160
Eligibility Criteria:
Inclusion Criteria:
* Documented atrial fibrillation (ECG, rhythm strip, device interrogation, discussion of an AF diagnosis in the participant's clinical report) within the past 10 years; paroxysmal, persistent or permanent
* Age \> 18 years
* Most recent visit for a patient having had a clinical visit with Investigator occurring within the past one year
Exclusion Criteria:
* Valvular AF (hemodynamically significant valvular heart disease including rheumatic mitral valve disease or at least moderate aortic valve stenosis)
* Life expectancy \< 12 months
* Active malignancy (treated or untreated)
* Indication for systemic anticoagulation independent of atrial fibrillation (venous thromboembolism, mechanical heart valve)
* Prior participation in any OAC randomized clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01733160
Study Brief:
Protocol Section:
NCT01733160